Belite Bio 宣佈委任醫學博士Hendrik P. N. Scholl 為首席醫療總監
September 03, 2024 20:16 ET
|
Belite Bio, Inc
在眼科領域，Scholl 博士是全球公認的領軍人物，同時也在史上規模最大的斯特格病變自然病史研究中擔任協調首席研究員 聖地牙哥, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE)（以下簡稱「Belite Bio」或「公司」）Belite Bio...
Belite Bio 宣布任命 Hendrik P. N. Scholl 医学博士为首席医学官
September 03, 2024 20:16 ET
|
Belite Bio, Inc
Scholl 博士是全球眼科领域备受推崇的领军人物，并在规模最大的斯特格病自然病程研究中担任协调首席研究员 圣迭戈, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc（纳斯达克股票代码：BLTE）（以下简称“Belite...
MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting
September 03, 2024 19:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...
ベライト・バイオ (Belite Bio)、ヘンドリック・P・N・ショル医学博士、修士 (Hendrik P. N. Scholl, MD, MA) をチーフ・メディカル・オフィサーに任命
September 03, 2024 19:00 ET
|
Belite Bio, Inc
ショル博士は眼科の分野で世界的に認められたリーダーであり、スターガルト病の史上最大規模の自然史研究の調整主任研究者 サンディエゴ発, Sept. 04, 2024 (GLOBE NEWSWIRE) -- アンメット・メディカル・ニーズの変性網膜疾患を対象とした新規治療薬の開発に注力する臨床段階のバイオ医薬品開発会社であるベライト・バイオ (Belite Bio, Inc) (NASDAQ:...
Business First Bancshares, Inc. Receives Regulatory Approval of its Merger with Oakwood Bancshares, Inc.
September 03, 2024 18:19 ET
|
b1BANK
BATON ROUGE, La., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (Business First) (Nasdaq: BFST), the holding company for b1BANK, announced it has received all required...
Cipher Mining Announces August 2024 Operational Update
September 03, 2024 18:05 ET
|
Cipher Mining Inc.
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for August 2024. Key...
Algoma Steel Group to Participate in the Jefferies 2024 Industrials Conference
September 03, 2024 17:30 ET
|
Algoma Steel Inc
SAULT STE. MARIE, Ontario, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel...
Hooker Furnishings Declares Quarterly Dividend
September 03, 2024 17:25 ET
|
Hooker Furnishings Corporation
MARTINSVILLE, Va., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on September 3, 2024, its board of directors declared a quarterly cash dividend...
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 03, 2024 17:14 ET
|
Royalty Pharma plc
NEW YORK and COPENHAGEN, Denmark, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Ascendis Pharma A/S (Nasdaq: ASND) today announced that Royalty Pharma and Ascendis Pharma...
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
September 03, 2024 17:06 ET
|
Ascendis Pharma
COPENHAGEN, Denmark and NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Ascendis Pharma Bone Diseases A/S,...